Insider Transactions in Q1 2023 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.06%
|
$1,100,000
$44.57 P/Share
|
|
Mar 29
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.72%
|
$475,000
$19.12 P/Share
|
|
Mar 13
2023
|
James R. Kasinger General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,305
-2.08%
|
$99,115
$43.22 P/Share
|
|
Mar 13
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,444
-1.21%
|
$406,092
$43.22 P/Share
|
|
Mar 11
2023
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+3.87%
|
-
|
|
Mar 11
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+2.25%
|
-
|
|
Mar 10
2023
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+4.91%
|
-
|
|
Mar 10
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,833
+2.96%
|
-
|
|
Feb 27
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.11%
|
$1,200,000
$48.49 P/Share
|
|
Feb 27
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.87%
|
$475,000
$19.12 P/Share
|
|
Feb 21
2023
|
James R. Kasinger General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,950
-3.61%
|
$93,600
$48.26 P/Share
|
|
Feb 21
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,373
-1.67%
|
$305,904
$48.26 P/Share
|
|
Feb 21
2023
|
Brendan Smith Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,392
-21.53%
|
$66,816
$48.26 P/Share
|
|
Feb 18
2023
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+6.61%
|
-
|
|
Feb 18
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,250
+3.35%
|
-
|
|
Feb 18
2023
|
Brendan Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+37.18%
|
-
|
|
Jan 27
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.19%
|
$1,275,000
$51.07 P/Share
|
|
Jan 27
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.97%
|
$475,000
$19.12 P/Share
|